Abstract:Objective To evaluate the feasibility of evaluating the major adverse events by liver stiffness using transient elastography in patients after left ventricular assist device implantation. Methods Fifty-six patients who underwent left ventricular assist device implantation were included in our study, and divided into events group and non-events group according to the presence of major adverse events or not. Blood examination and heart function test were performed before operation. FibroScan was used to check the liver stiffness before and after operation. SPSS 19.0 was used to analyze the risk factors for postoperative adverse events, and ROC curve was used to analyze the veracity of the method. Results The liver stiffness of the events group was higher than that of the non-events group (P < 0.05); the liver stiffness was lowered 1 week after operation, which was still lower in the non-events group than in the events group (P < 0.05). Four weeks after operation, the liver stiffness lowered in both groups and was still significantly different from the preoperative one (P < 0.05), but there was no significant difference between the two groups (P > 0.05). Logistic regression analysis showed liver stiffness is a risk factor of the major adverse events after left ventricular assist device implantation, and ROC curve showed the area under curve was 0.853, the sensitivity was 0.826 and the specificity was 0.736. Conclusions Liver stiffness is a risk factor of postoperative adverse events after left ventricular assist device implantation operation. Transient elastography can be used as a non-invasive detection method before left ventricular assist device implantation operation, to help verify the severity of the disease and forecast the occurrence of major adverse events.